Webinar: Now What? Cross-Border Data Transfers after Schrems II

Sep 2, 2020 by BBB National Programs

The recent Court of Justice of the European Union (CJEU) decision known as Schrems II has created an atmosphere of uncertainty for all businesses that rely on the transfer of personal data from the EU to the U.S. This includes the more than 5,000 Privacy Shield businesses and many others that rely on other mechanisms for EU-U.S. transfers, all of which were called into question by the CJEU.

To shed light on this developing situation, BigID hosted a webinar discussion with a panel of privacy experts. BBB National Programs’ Cobun Zweifel-Keegan, Deputy Director, Privacy Initiatives, was joined by Hogan Lovells' Julian Flamant, Accenture's Ben Shorten, and BigID’s Heather Federman.

The webinar covers:

  • The context and history of the Schrems II case,
  • The challenges businesses are facing in this time of uncertainty,
  • The top considerations for privacy professionals as they ponder how to approach the future of cross-border data transfers, and
  • Projections on the long-term implications of trade relations between the EU and the U.S.

For further analysis of the CJEU decision, check out our blog, Schrems II: What Do Privacy Shield Businesses Need to Know?

For more information on BigID, which helps organizations “know their data” with automated data mapping and discovery solutions, please visit the BigID website.

Suggested Articles

Blog

What All Businesses Can Learn From Recent Missteps In Crypto

While the crypto market itself is quite revolutionary, its challenges in introducing a new concept to consumers are not new. In every emerging market, business leaders should take steps to generate excitement while being careful to avoid pitfalls by making advertising claims that they can support with evidence.
Read more
Blog

Expanding SWIFT: What’s New for 2023

NAD is expanding Fast-Track SWIFT so that all single-issue claims, express and implied, that do not require review of complex evidence or substantiation are eligible. In SWIFT, challenges are limited to issues that do not require review of complex evidence or substantiation, such as clinical or technical testing or consumer perception evidence, and cases are resolved within 20 business days or less.
Read more
Blog

FTC’s New Health Claims Guidance: What You Need to Know

Health-related claims remain a priority for the Federal Trade Commission (FTC), signaled by the release of important new guidance at the end of 2022: Health Products Compliance Guidance, replacing the Dietary Supplements: An Advertising Guide for Industry. Get to know these changes for health-related claims.
Read more
Blog

2023 Trends: Big Game Ad Claims

What makes the Super Bowl “super”? The commercials. In recent years the explosion of increased marketing channels has led marketers to flock to targeted advertising, but the big game stage provides an important opportunity to reach millions of consumers at the same time. This article takes a look at some of the trends from this year’s big game.
Read more